Virtual reality exposure and response prevention in the treatment of obsessive-compulsive disorder in patients with contamination subtype in comparison with in vivo exposure therapy: a randomized clinical controlled trial

Razieh Javaherirenani, Seyede Salehe Mortazavi, Mohammadreza Shalbafan, Ahmad Ashouri, Abbas Ramezani Farani

BMC Psychiatry · 2022 · 25 citations · 30 references

DOIFull text

Open access

Abstract

Iranian Registry of Clinical Trials, IRCT ID: IRCT20210214050353N1 , Registered on 16/10/2021.

References

30